Genomics-Based Target Therapy for Children With Relapsed or Refractory Malignancy

Clinical trial NCT02638428 · UNKNOWN

Trial details

NCT number: NCT02638428
Sponsor: Samsung Medical Center
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Relapsed Pediatric Solid Tumor Refractory Pediatric Solid Tumor Relapsed Pediatric AML Refractory Pediatric AML

Start date: 2015-12-01
Primary completion: 2021-12-01
Enrollment: 90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.